The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: clindamycin     Quarter: 2016Q3

Total Drug/Injury Combinations: 475     Number of Pages: 24

DRUGNAME PT EventCount
CLINDAMYCIN HCL Chest pain 1 view events
CLINDAMYCIN HCL Cholecystitis 1 view events
CLINDAMYCIN HCL Clavicle fracture 1 view events
CLINDAMYCIN HCL Clostridium difficile infection 1 view events
CLINDAMYCIN HCL Constipation 1 view events
CLINDAMYCIN HCL Dehydration 1 view events
CLINDAMYCIN HCL Diarrhoea neonatal 1 view events
CLINDAMYCIN HCL Dysphagia 1 view events
CLINDAMYCIN HCL Eosinophilia 1 view events
CLINDAMYCIN HCL Epicondylitis 1 view events
CLINDAMYCIN HCL Exposure during breast feeding 1 view events
CLINDAMYCIN HCL Face oedema 1 view events
CLINDAMYCIN HCL Fatigue 1 view events
CLINDAMYCIN HCL Feeling abnormal 1 view events
CLINDAMYCIN HCL Fungal infection 1 view events
CLINDAMYCIN HCL Gastrointestinal disorder 1 view events
CLINDAMYCIN HCL Haematochezia 1 view events
CLINDAMYCIN HCL Helicobacter infection 1 view events
CLINDAMYCIN HCL Hepatotoxicity 1 view events
CLINDAMYCIN HCL Hypertension 1 view events

Total Drug/Injury Combinations: 475     Number of Pages: 24

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)